N@N

ACHN, DARA, OPTR, CORE, LINE, DDE Are Seasonally Ripe To Go Down In the Next Five Weeks

August 14, 2012 / M2 PRESSWIRE / BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of Achillion Pharmaceuticals Inc (NASDAQ:ACHN), DARA Biosciences Inc (NASDAQ:DARA), Optimer Pharmaceuticals Inc (NASDAQ:OPTR), Core Mark Holding Co Inc (NASDAQ:CORE), Linn Energy LLC (NASDAQ:LINE), Dover Downs Gaming & Entertainment Inc (NYSE:DDE) and each have a high seasonal probability to go Down in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at: http://www.squeezetrigger.com/services/strat/mh.php

The following stocks are expected to go Down:

  Symbol  Company                          Expected Return  Odds                 By The Following Date
  ACHN    Achillion Pharmaceuticals Inc    -1.76%           100.00% (5 of 5)     Wednesday, August 15th 2012
  DARA    DARA Biosciences Inc             -11.73%          81.82% (9 of 11)     Wednesday, August 22nd 2012
  OPTR    Optimer Pharmaceuticals Inc      -2.66%           100.00% (5 of 5)     Wednesday, August 15th 2012
  CORE    Core Mark Holding Co Inc         -3.88%           100.00% (6 of 6)     Wednesday, September 5th 2012
  LINE    Linn Energy LLC                  -2.89%           100.00% (6 of 6)     Wednesday, September 5th 2012
  DDE     Dover Downs Gaming & Entertainment Inc  -9.14%           90.00% (9 of 10)     Wednesday, September 26th 2012

Achillion Pharmaceuticals Inc (NASDAQ:ACHN) - Achillion Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of treatments for infectious diseases. The company focuses on the development of antivirals for the treatment of chronic hepatitis C; and the development of antibacterials for the treatment of resistant bacterial infections. Its drug candidate pipeline includes ACH-1625, a protease inhibitor, which is in phase 1/b clinical trials for the treatment of chronic hepatitis C infections; ACH-1095, a NS4A antagonist that is in late-stage preclinical studies for the treatment of chronic hepatitis C infections; and ACH-2684, a protease inhibitor, which is in late stage preclinical testing. The companys other product candidates comprise ACH-702, which is in preclinical stage for the treatment of serious bacterial infections; and Elvucitabine that is in phase II clinical trials for the treatment of HIV infection. The company has a collaboration arrangement with Gilead Sciences, Inc. to develop and commercialize compounds for the treatment of chronic hepatitis C, which inhibit viral replication through a mechanism of action. Achillion Pharmaceuticals, Inc. was founded in 1998 and is based in New Haven, Connecticut.

DARA Biosciences Inc (NASDAQ:DARA) - DARA BioSciences, Inc., a development-stage pharmaceutical company, acquires promising therapeutic small molecules and develops them through proof of concept in humans for subsequent sale or out-licensing to larger pharmaceutical companies. The company has two drug candidates in development with cleared investigational new drug applications from the U.S. Food and Drug Administration. Its drug development programs include KRN5500, which completed a Phase IIa clinical trial for the treatment of neuropathic pain in cancer patients; and DB959 for the treatment of metabolic diseases, including type 2 diabetes. The company is headquartered in Raleigh, North Carolina.

Optimer Pharmaceuticals Inc (NASDAQ:OPTR) - Optimer Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing anti-infective products worldwide. It develops products that treat gastrointestinal infections and related diseases. The companys two late-stage anti-infective product candidates include Fidaxomicin, the lead product candidate and an antibiotic for the treatment of clostridium difficile-infections, which completed two Phase III clinical trial; and Prulifloxacin, a prodrug in the fluoroquinolone class of antibiotics, which completed two Phase III trials for the treatment of infectious diarrhea, including travelers diarrhea. It also develops product candidates using its proprietary technology Optimer One-Pot Synthesis, a drug discovery platform and a computer-aided technology that enables the synthesis of carbohydrate-based compounds. In addition, the companys other pipeline product candidates consist of CEM-101 (OP-1068), a macrolide and ketolide antibiotic for the treatment of upper and lower respiratory tract infections; OPT-88, a disease-modifying intra-articular therapy for osteoarthritis; and OPT-822/OPT-821, a carbohydrate-based immunostimulant therapy for the treatment of metastatic breast cancer. Additionally, it licensed rights to Cempra Pharmaceuticals, Inc. to develop CEM-101; and granted rights to Optimer Biopharmaceuticals, Inc. to develop OPT-88 and OPT-822/821. Further, the company has collaborative agreements with Par Pharmaceuticals, Inc.; Nippon Shinyaku, Co., Ltd.; Memorial Sloan-Kettering Cancer Center; and Scripps Research Institute. Optimer Pharmaceuticals was founded in 1998 and is based in San Diego, California.

Core Mark Holding Co Inc (NASDAQ:CORE) - Core-Mark Holding Company, Inc., together with its subsidiaries, engages in the business of distributing packaged consumer products to convenience retail stores in the United States and Canada. It distributes approximately 42,000 stock keeping units of packaged consumable goods, including cigarettes, tobacco products, candy, snacks, fast food, fresh products, groceries, dairy, non-alcoholic beverages, general merchandise, and health and beauty care products. The company also serves grocery stores, drug stores, liquor stores, and other stores that carry convenience products. As of March 12, 2010, it provided distribution and logistics services, as well as marketing programs to approximately 24,000 retail locations in 50 states, and 5 Canadian provinces through 26 distribution centers. The company was founded in 1888 and is headquartered in South San Francisco, California.

Linn Energy LLC (NASDAQ:LINE) - Linn Energy, LLC, an independent oil and natural gas company, engages in the development and acquisition of oil and gas properties in the United States. The company holds interests in various properties located in Oklahoma, Kansas, Louisiana, Illinois, Michigan, and California, as well as located in the Permian Basin in west Texas and southeast New Mexico. As of December 31, 2010, it had proved reserves of 2,597 billion cubic feet equivalent of oil and gas, and natural gas liquids, as well as operated 7,097 gross productive wells. The company was founded in 2003 and is headquartered in Houston, Texas.

Dover Downs Gaming & Entertainment Inc (NYSE:DDE) - Dover Downs Gaming & Entertainment, Inc., through its subsidiaries, operates as a gaming and entertainment company in the United States. The companys operations consist of Dover Downs Casino, a 165,000 square foot video lottery casino complex featuring slot machine offerings, including multi-player electronic table, and a race and sports book; the Dover Downs Hotel and Conference Center, a 500 room AAA Four Diamond hotel with conference, banquet, ballroom, and concert hall; and Dover Downs Raceway, a harness racing track with pari-mutuel wagering on live and simulcast horse races. As of December 31, 2009, it operated 2,971 slot machines; and Dover Downs Hotel featured 500 rooms, a multipurpose ballroom/concert hall, a dining restaurant, swimming pool, and spa. The company was founded in 1969 and is based in Dover, Delaware. As of March 31, 2002, Dover Downs Gaming & Entertainment Inc. operates independently of Dover Motorsports Inc.

SqueezeTrigger.com has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com

www.squeezetrigger.com monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements".

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO.

INVESTMENTS & TRADING

SqueezeTrigger -- 25 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

About SQUEEZETRIGGER.COM

WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.

SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data.

The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha'a"s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.

All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.

Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.

By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.

Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.

Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.

Contact: Thomas Ronk, CEO www.squeezetrigger.com +1-800-715-9999 Tom@squeezetrigger.com

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641